Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Teleflex Inc (TFX)

Teleflex Inc (TFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,704,999
  • Shares Outstanding, K 46,444
  • Annual Sales, $ 2,974 M
  • Annual Income, $ 356,330 K
  • EBIT $ 385 M
  • EBITDA $ 630 M
  • 60-Month Beta 1.18
  • Price/Sales 3.01
  • Price/Cash Flow 10.25
  • Price/Book 2.00

Options Overview Details

View History
  • Implied Volatility 25.25% ( +0.44%)
  • Historical Volatility 50.37%
  • IV Percentile 19%
  • IV Rank 31.20%
  • IV High 39.16% on 02/21/24
  • IV Low 18.94% on 05/07/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 29
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 413
  • Open Int (30-Day) 384

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 3.86
  • Number of Estimates 14
  • High Estimate 3.95
  • Low Estimate 3.77
  • Prior Year 3.38
  • Growth Rate Est. (year over year) +14.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
185.66 +2.68%
on 11/20/24
239.46 -20.39%
on 10/24/24
-45.78 (-19.36%)
since 10/21/24
3-Month
185.66 +2.68%
on 11/20/24
249.90 -23.72%
on 09/27/24
-47.63 (-19.99%)
since 08/21/24
52-Week
185.66 +2.68%
on 11/20/24
257.85 -26.07%
on 12/18/23
-25.93 (-11.97%)
since 11/21/23

Most Recent Stories

More News
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference

TFX : 190.64 (+1.71%)
Teleflex to Present at the Jefferies London Healthcare Conference

TFX : 190.64 (+1.71%)
Teleflex Announces Quarterly Dividend

TFX : 190.64 (+1.71%)
Teleflex: Q3 Earnings Snapshot

Teleflex: Q3 Earnings Snapshot

TFX : 190.64 (+1.71%)
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook

TFX : 190.64 (+1.71%)
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)

TFX : 190.64 (+1.71%)
Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada

TFX : 190.64 (+1.71%)
Earnings Preview: What to Expect From Teleflex's Report

Teleflex is set to report its third-quarter earnings by the end of this month, with analysts projecting a slight decline in its bottom line.

XLV : 144.03 (+0.80%)
$SPX : 5,948.71 (+0.53%)
TFX : 190.64 (+1.71%)
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigelâ„¢ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)

TFX : 190.64 (+1.71%)
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information

TFX : 190.64 (+1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company...

See More

Key Turning Points

3rd Resistance Point 195.85
2nd Resistance Point 193.54
1st Resistance Point 192.09
Last Price 190.64
1st Support Level 188.33
2nd Support Level 186.02
3rd Support Level 184.57

See More

52-Week High 257.85
Fibonacci 61.8% 230.27
Fibonacci 50% 221.76
Fibonacci 38.2% 213.24
Last Price 190.64
52-Week Low 185.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar